Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Admission of New Shares

22nd Jun 2009 10:35

RNS Number : 2613U
Allergy Therapeutics PLC
22 June 2009
 



Monday 22 June 2009

Allergy Therapeutics plc

("Allergy Therapeutics" or "the Company")

Admission of New Shares Pursuant to Exercise of Options

Allergy Therapeutics plc (AIM: AGY), the specialist pharmaceutical company focused on allergy vaccination, announces that is has applied for admission of 415,982 Ordinary Shares of 0.1 pence ("Admission") each pursuant to the exercise of options announced 12 June 2009. Admission is expected to be on or around Wednesday 24 June 2009.

After Admission of the 415,982 shares, the issued share capital of the Company will be 82,366,614 Ordinary Shares.

For further information

Allergy Therapeutics

+44 (0) 1903 845 820

Keith Carter, Chief Executive

www.allergytherapeutics.com

Nomura Code Securities

+44 (0) 207 776 1200

Juliet Thompson/ Clare Terlouw

Financial Dynamics

+44 (0) 207 831 3113

Ben Brewerton

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISSELSUESUSEDM

Related Shares:

Allergy Thera.
FTSE 100 Latest
Value8,601.09
Change58.53